Projects per year
Search results
-
Active
Treatment practices and outcomes of adults with therapy-related acute myeloid leukemia (AML), secondary AML and AML with myelodysplasia related changes
Maakaron, J. (PI) & He, F. (Prior Principal Investigator)
UNIVERSITY OF NEBRASKA MEDICAL CENTER, JAZZ PHARMACEUTICALS, INC.
1/29/20 → 6/30/25
Project: Research project
-
Finished
A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR0191 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia
Maakaron, J. (PI) & He, F. (Prior Principal Investigator)
4/7/20 → 4/30/25
Project: Research project
-
“A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR0191 in Subjects with Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leuke
He, F. (PI)
4/7/20 → 4/30/25
Project: Research project
-
HM2017-33 : Nivolumab and Oral Cyclophosphamide for Rela
Maakaron, J. (PI), He, F. (Prior Principal Investigator) & Weisdorf, D. J. (Prior Principal Investigator)
11/1/17 → 4/30/23
Project: Research project
-
Immune Monitoring During ASP2215 Therapy in Relapsed/Ref
He, F. (PI) & Ustun, C. (Prior Principal Investigator)
5/1/16 → 3/31/21
Project: Research project